VR Logo

Par Drugs And Chemicals Ltd. download report


Chemicals | Inorganic Chem.

Par Drugs And Chemicals Ltd. Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Par Drugs And Chemicals Ltd. chairman speech Par Drugs And Chemicals Ltd. director's report Par Drugs And Chemicals Ltd. management discussion Par Drugs And Chemicals Ltd. corporate governance Par Drugs And Chemicals Ltd. auditor's report Par Drugs And Chemicals Ltd. account notes
2020 Par Drugs And Chemicals Ltd. Annual Report Par Drugs And Chemicals Ltd. chairman speech Par Drugs And Chemicals Ltd. director's report Par Drugs And Chemicals Ltd. management discussion Par Drugs And Chemicals Ltd. corporate governance Par Drugs And Chemicals Ltd. auditor's report Par Drugs And Chemicals Ltd. account notes
2019 Par Drugs And Chemicals Ltd. Annual Report Par Drugs And Chemicals Ltd. chairman speech Par Drugs And Chemicals Ltd. director's report Par Drugs And Chemicals Ltd. management discussion Par Drugs And Chemicals Ltd. corporate governance Par Drugs And Chemicals Ltd. auditor's report Par Drugs And Chemicals Ltd. account notes
2017 Par Drugs And Chemicals Ltd. Annual Report Par Drugs And Chemicals Ltd. chairman speech Par Drugs And Chemicals Ltd. director's report Par Drugs And Chemicals Ltd. management discussion Par Drugs And Chemicals Ltd. corporate governance Par Drugs And Chemicals Ltd. auditor's report Par Drugs And Chemicals Ltd. account notes
2016 Par Drugs And Chemicals Ltd. Annual Report Par Drugs And Chemicals Ltd. chairman speech Par Drugs And Chemicals Ltd. director's report Par Drugs And Chemicals Ltd. management discussion Par Drugs And Chemicals Ltd. corporate governance Par Drugs And Chemicals Ltd. auditor's report Par Drugs And Chemicals Ltd. account notes

About The Company

Business: Manufacture of organic and inorganic chemical compounds n.e.c.

Incorporated: 1999

Chairman: Falgun Vallabhbhai Savani

Managing Director: Falgun Vallabhbhai Savani

Listing: NSE: PAR

Country: India

Headquarters: Vadodara, Gujarat

Website: www.pardrugs.com

Key Facts

Market cap: ₹174.54 Cr

Revenue (TTM): ₹60.75 Cr

Earnings (TTM): ₹11.61 Cr

Cash: ₹21.16 Cr

Total Debt: ₹8.32 Cr

Promoters' ownership: 74.21%

Liquidity: Low

52 Week range: ₹87.00 - 310.60

Face value: ₹10.00

Shares outstanding: 1,23,04,636

10 Years Aggregate:

  • CFO: ₹34.31 Cr
  • EBITDA: ₹78.56 Cr
  • Net Profit: ₹26.31 Cr

Stock Performance

Time Period Par Drugs And Chemicals S&P BSE Basic Materials S&P BSE Small Cap
YTD-29.52-17.60-15.79
1 month-5.56-9.73-5.93
3 months-11.21-20.70-12.08
1 Year63.05-12.01-1.68
3 Years80.8016.7720.33
5 Years--9.629.99
10 Years----14.26
As on 01-Jul-2022
Year Par Drugs And Chemicals S&P BSE Small Cap S&P BSE Basic Materials
2021470.1162.7761.53
202065.5332.1126.07